• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肾病患儿及肾移植后的代谢综合征

Metabolic syndrome in children with chronic kidney disease and after renal transplantation.

作者信息

Litwin Mieczysław, Niemirska Anna

机构信息

Department of Nephrology and Arterial Hypertension, The Children's Memorial Health Institute, Warsaw, Poland,

出版信息

Pediatr Nephrol. 2014 Feb;29(2):203-16. doi: 10.1007/s00467-013-2500-1. Epub 2013 Jun 13.

DOI:10.1007/s00467-013-2500-1
PMID:23760991
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3889828/
Abstract

Visceral obesity and metabolic abnormalities typical for metabolic syndrome (MS) are the new epidemic in adolescence. MS is not only the risk factor for cardiovascular disease but also for chronic kidney disease (CKD). Thus, there are some reasons to recognize MS as a new challenge for pediatric nephrologists. First, hypertensive and diabetic nephropathy, the main causes of CKD in adults, both share the same pathophysiological abnormalities associated with visceral obesity and insulin resistance and have their origins in childhood. Secondly, as the obesity epidemic also affects children with CKD, MS emerges as the risk factor for progression of CKD. Thirdly, metabolic abnormalities typical for MS may pose additional risk for cardiovascular morbidity and mortality in children with CKD. Finally, although the renal transplantation reverses uremic abnormalities it is associated with an exposure to new metabolic risk factors typical for MS and MS has been found to be the risk factor for graft loss and cardiovascular morbidity after renal transplantation. MS is the result of imbalance between dietary energy intake and expenditure inducing disproportionate fat accumulation. Thus, the best prevention and treatment of MS is physical activity and maintenance of proper relationship between lean and fat mass.

摘要

内脏肥胖以及代谢综合征(MS)特有的代谢异常是青少年中的新流行病。MS不仅是心血管疾病的危险因素,也是慢性肾脏病(CKD)的危险因素。因此,有一些理由将MS视为儿科肾病学家面临的新挑战。首先,成人CKD的主要病因——高血压和糖尿病肾病,都具有与内脏肥胖和胰岛素抵抗相关的相同病理生理异常,且都起源于儿童期。其次,由于肥胖流行也影响CKD儿童,MS成为CKD进展的危险因素。第三,MS特有的代谢异常可能给CKD儿童的心血管发病和死亡带来额外风险。最后,尽管肾移植可逆转尿毒症异常,但它与暴露于MS特有的新代谢危险因素有关,并且已发现MS是肾移植后移植物丢失和心血管发病的危险因素。MS是饮食能量摄入与消耗失衡导致脂肪过度积累的结果。因此,预防和治疗MS的最佳方法是体育活动以及维持瘦体重与脂肪量之间的适当关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/5d1e9e6aaec7/467_2013_2500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/4f7e88f4d535/467_2013_2500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/58adbf5599b0/467_2013_2500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/5d1e9e6aaec7/467_2013_2500_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/4f7e88f4d535/467_2013_2500_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/58adbf5599b0/467_2013_2500_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ce13/3889828/5d1e9e6aaec7/467_2013_2500_Fig3_HTML.jpg

相似文献

1
Metabolic syndrome in children with chronic kidney disease and after renal transplantation.慢性肾病患儿及肾移植后的代谢综合征
Pediatr Nephrol. 2014 Feb;29(2):203-16. doi: 10.1007/s00467-013-2500-1. Epub 2013 Jun 13.
2
Assessment and management of obesity and metabolic syndrome in children with CKD stages 2-5 on dialysis and after kidney transplantation-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.儿童慢性肾脏病 2-5 期透析和肾移植后肥胖和代谢综合征的评估和管理——儿科肾脏营养工作组的临床实践建议。
Pediatr Nephrol. 2022 Jan;37(1):1-20. doi: 10.1007/s00467-021-05148-y. Epub 2021 Aug 10.
3
[Obesity in metabolic syndrome, as well as kidney dysfunction].
Ter Arkh. 2016;88(10):93-98. doi: 10.17116/terarkh201688693-98.
4
Prevalence of Chronic Kidney Disease in Turkish Adults With Obesity and Metabolic Syndrome: A Post Hoc Analysis from Chronic Renal Disease in Turkey Study.土耳其肥胖与代谢综合征成年患者慢性肾脏病的患病率:来自土耳其慢性肾脏病研究的事后分析
J Ren Nutr. 2016 Nov;26(6):373-379. doi: 10.1053/j.jrn.2016.08.004. Epub 2016 Sep 15.
5
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 6. CKD associated with obesity and metabolic syndrome].[慢性肾脏病(CKD)——近期进展。主题:六、慢性肾脏病(CKD)及相关病症;6. 与肥胖和代谢综合征相关的CKD]
Nihon Naika Gakkai Zasshi. 2012 May 10;101(5):1310-7. doi: 10.2169/naika.101.1310.
6
Impact of metabolic syndrome on resting energy expenditure in patients with chronic kidney disease.代谢综合征对慢性肾脏病患者静息能量消耗的影响。
Clin Nutr ESPEN. 2016 Oct;15:107-113. doi: 10.1016/j.clnesp.2016.07.001. Epub 2016 Aug 18.
7
Metabolic syndrome in chronic kidney disease and renal transplant patients in North India.印度北部慢性肾脏病和肾移植患者的代谢综合征。
Int Urol Nephrol. 2012 Jun;44(3):937-43. doi: 10.1007/s11255-011-9998-6. Epub 2011 Jun 10.
8
Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program.
J Bras Nefrol. 2017 Jul-Sep;39(3):246-252. doi: 10.5935/0101-2800.20170040. Epub 2017 Aug 28.
9
The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.肥胖及其生物临床相关因素在慢性肾脏病进展中的作用。
Adv Chronic Kidney Dis. 2006 Oct;13(4):352-64. doi: 10.1053/j.ackd.2006.07.010.
10
Obesity and metabolic syndrome in kidney transplantation.肥胖与代谢综合征与肾移植
Curr Hypertens Rep. 2013 Jun;15(3):215-23. doi: 10.1007/s11906-013-0335-6.

引用本文的文献

1
Relation between obesity-related comorbidities and kidney function estimation in children.肥胖相关合并症与儿童肾功能评估的关系。
Pediatr Nephrol. 2023 Jun;38(6):1867-1876. doi: 10.1007/s00467-022-05810-z. Epub 2022 Nov 22.
2
Malnutrition and immune cell subsets in children undergoing kidney transplantation.儿童肾移植患者的营养不良与免疫细胞亚群。
Pediatr Transplant. 2022 Dec;26(8):e14371. doi: 10.1111/petr.14371. Epub 2022 Aug 8.
3
Left ventricular stiffness in paediatric patients with end-stage kidney disease.儿科终末期肾病患者的左心室僵硬度。

本文引用的文献

1
Role of Renin-Angiotensin system and oxidative stress on vascular inflammation in insulin resistence model.肾素-血管紧张素系统和氧化应激在胰岛素抵抗模型中对血管炎症的作用
Int J Hypertens. 2013;2013:420979. doi: 10.1155/2013/420979. Epub 2013 Jan 8.
2
Ghrelin and leptin pathophysiology in chronic kidney disease.慢性肾脏病中的 ghrelin 和 leptin 病理生理学。
Pediatr Nephrol. 2013 Apr;28(4):611-6. doi: 10.1007/s00467-012-2380-9. Epub 2012 Dec 11.
3
Mechanistic insights into vascular calcification in CKD.CKD 中血管钙化的机制研究。
Pediatr Nephrol. 2020 Jun;35(6):1051-1060. doi: 10.1007/s00467-020-04484-9. Epub 2020 Feb 3.
4
Depression and neurocognitive dysfunction in pediatric and young adult chronic kidney disease.儿童和青年慢性肾脏病中的抑郁和神经认知功能障碍。
Pediatr Nephrol. 2019 Sep;34(9):1575-1582. doi: 10.1007/s00467-019-04265-z. Epub 2019 May 2.
5
Cardiometabolic Risk Factors, Metabolic Syndrome, and Chronic Kidney Disease Progression in Children.心血管代谢危险因素、代谢综合征与儿童慢性肾脏病进展。
J Pediatr. 2018 Nov;202:163-170. doi: 10.1016/j.jpeds.2018.06.007. Epub 2018 Jul 2.
6
Non-immunologic allograft loss in pediatric kidney transplant recipients.儿科肾移植受者的非免疫性同种异体移植物丢失。
Pediatr Nephrol. 2019 Feb;34(2):211-222. doi: 10.1007/s00467-018-3908-4. Epub 2018 Feb 26.
7
Hypertension in pediatric patients with chronic kidney disease: management challenges.慢性肾病患儿的高血压:管理挑战
Int J Nephrol Renovasc Dis. 2017 Jul 26;10:205-213. doi: 10.2147/IJNRD.S100891. eCollection 2017.
8
Long-term effects of paediatric kidney transplantation.儿科肾移植的长期影响。
Nat Rev Nephrol. 2016 May;12(5):301-11. doi: 10.1038/nrneph.2015.197. Epub 2015 Dec 14.
9
Paediatric obesity and renal transplantation: current challenges and solutions.小儿肥胖与肾移植:当前挑战与解决方案
Pediatr Nephrol. 2016 Apr;31(4):555-62. doi: 10.1007/s00467-015-3126-2. Epub 2015 May 28.
10
Paediatrics, insulin resistance and the kidney.儿科学、胰岛素抵抗与肾脏
Pediatr Nephrol. 2015 Aug;30(8):1217-24. doi: 10.1007/s00467-014-2890-8. Epub 2014 Jul 25.
J Am Soc Nephrol. 2013 Feb;24(2):179-89. doi: 10.1681/ASN.2011121191. Epub 2012 Nov 8.
4
Effects of fibrates in kidney disease: a systematic review and meta-analysis.贝特类药物在肾脏病中的作用:系统评价和荟萃分析。
J Am Coll Cardiol. 2012 Nov 13;60(20):2061-71. doi: 10.1016/j.jacc.2012.07.049. Epub 2012 Oct 17.
5
Link between the renin-angiotensin system and insulin resistance: implications for cardiovascular disease.肾素-血管紧张素系统与胰岛素抵抗的关系:对心血管疾病的影响。
Vasc Med. 2012 Oct;17(5):330-41. doi: 10.1177/1358863X12450094. Epub 2012 Jul 19.
6
Oxidative stress in hypertensive children before and after 1 year of antihypertensive therapy.高血压儿童在接受降压治疗 1 年前和后,其氧化应激状态的变化。
Pediatr Nephrol. 2012 Oct;27(10):1943-51. doi: 10.1007/s00467-012-2193-x. Epub 2012 Jun 2.
7
Metformin therapy in patients with chronic kidney disease.二甲双胍治疗慢性肾脏病患者。
Diabetes Obes Metab. 2012 Oct;14(10):963-5. doi: 10.1111/j.1463-1326.2012.01617.x. Epub 2012 May 27.
8
Pedometer-assessed physical activity in children and young adults with CKD.使用计步器评估慢性肾脏病儿童和青少年的身体活动。
Clin J Am Soc Nephrol. 2012 May;7(5):720-6. doi: 10.2215/CJN.06330611. Epub 2012 Mar 15.
9
Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome.比索洛尔和美托洛尔对代谢综合征胰岛素敏感性和纤溶酶原激活物抑制剂的差异作用。
Hypertension. 2012 Apr;59(4):893-8. doi: 10.1161/HYPERTENSIONAHA.111.189589. Epub 2012 Feb 21.
10
Toward a unifying hypothesis of metabolic syndrome.迈向代谢综合征统一假说。
Pediatrics. 2012 Mar;129(3):557-70. doi: 10.1542/peds.2011-2912. Epub 2012 Feb 20.